NeuroSense Therapeutics Ltd. Restricted Cash and Investments, Current
NeuroSense Therapeutics Ltd. (NRSN) had Restricted Cash and Investments, Current of $47.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashAndInvestmentsCurrent · last filed 2026-03-31
- 2025-12-31: Restricted Cash and Investments, Current $47.00K.
- 2025-06-30: Restricted Cash and Investments, Current $43.00K.
- 2024-12-31: Restricted Cash and Investments, Current $35.00K.
- 2024-06-30: Restricted Cash and Investments, Current $35.00K.
| Period end | Restricted Cash and Investments, Current |
|---|---|
| 2025-12-31 | $47.00K 20-F · filed 2026-03-31 |
| 2025-06-30 | $43.00K 6-K · filed 2025-08-01 |
| 2024-12-31 | $35.00K 20-F · filed 2026-03-31 |
| 2024-06-30 | $35.00K 6-K · filed 2024-09-30 |
| 2023-12-31 | $40.00K 20-F · filed 2025-04-07 |
| 2022-12-31 | $36.00K 6-K · filed 2024-06-17 |